title: Budd-Chiari syndrome secondary to antiphospholipid syndrome: clinical and immunologic characteristics of 43 patients.
authors.affiliation: Systemic Autoimmune Diseases Unit, Institut Clínic d'Infeccions i Immunologia, August Pi i Sunyer, Hospital Clínic, Barcelona, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Espinosa
authors.forename: J
authors.initials: J
authors.lastname: Font
authors.forename: J C
authors.initials: JC
authors.lastname: García-Pagan
authors.forename: D
authors.initials: D
authors.lastname: Tàssies
authors.forename: J C
authors.initials: JC
authors.lastname: Reverter
authors.forename: C
authors.initials: C
authors.lastname: Gaig
authors.forename: F
authors.initials: F
authors.lastname: Cervantes
authors.forename: R
authors.initials: R
authors.lastname: Cervera
authors.forename: J
authors.initials: J
authors.lastname: Bosch
authors.forename: M
authors.initials: M
authors.lastname: Ingelmo
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000150:complications*; D015415:Biomarkers; D006502:Budd-Chiari Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D015984:Causality; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D015415:Biomarkers